J Korean Pediatr Soc.  1999 Apr;42(4):576-579.

Levamisole-Induced Reversible Agranulocytosis in Children with Steroid Dependent Nephrotic Syndrome

Affiliations
  • 1Department of Pediatrics, College of Medicine, Ewha Womans University, Seoul, Korea.

Abstract

Levamisole has been used for nephrotic syndrome due to its immunostimulating, immunomodulating, and steroid-sparing effects. Agranulocytosis, a serious side effect of levamisole, was rare and mostly associated with autoimmune disease, neoplastic disease and HLA B27 except one case in a nephrotic syndrome who was treated with high-dose(5mg/kg QOD) levamisole. This 15 year-old girl with steroid dependent nephrotic syndrome, who was negative for HLA B27, was treated with the usual recommended dose of levamisole(2.5mg/kg QOD). She developed agranulocytosis after 5 weeks of therapy and completely recovered in 11 days after discontinuation of levamisole.

Keyword

Levamisole; Agranulocytosis; Steroid dependent nephrotic syndrome

MeSH Terms

Adolescent
Agranulocytosis*
Autoimmune Diseases
Child*
Female
Humans
Levamisole
Nephrotic Syndrome*
Levamisole
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr